Cargando…

Serum lipid profile of Parkinson's disease patients: A study from the Northwest of Iran

BACKGROUND: Parkinson's disease (PD) is defined as a long-lasting, neurological illness. Low levels of serum lipid fractions are related with a high risk of PD. Current investigation was designed to evaluate the concentration blood lipid fractions in patients suffering from PD and compared with...

Descripción completa

Detalles Bibliográficos
Autores principales: Saedi, Samira, Hemmati-Dinarvand, Mohsen, Barmaki, Haleh, Mokhtari, Zohreh, Musavi, Hadis, Valilo, Mohamad, Mota, Ali, Mahjoub, Soleiman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Babol University of Medical Sciences 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111816/
https://www.ncbi.nlm.nih.gov/pubmed/34012532
http://dx.doi.org/10.22088/cjim.12.2.155
_version_ 1783690573931085824
author Saedi, Samira
Hemmati-Dinarvand, Mohsen
Barmaki, Haleh
Mokhtari, Zohreh
Musavi, Hadis
Valilo, Mohamad
Mota, Ali
Mahjoub, Soleiman
author_facet Saedi, Samira
Hemmati-Dinarvand, Mohsen
Barmaki, Haleh
Mokhtari, Zohreh
Musavi, Hadis
Valilo, Mohamad
Mota, Ali
Mahjoub, Soleiman
author_sort Saedi, Samira
collection PubMed
description BACKGROUND: Parkinson's disease (PD) is defined as a long-lasting, neurological illness. Low levels of serum lipid fractions are related with a high risk of PD. Current investigation was designed to evaluate the concentration blood lipid fractions in patients suffering from PD and compared with healthy subjects. METHODS: This case-control study was conducted from February 2016 to September 2018 in Tabriz University of Medical Sciences, Tabriz, Iran. The present investigation consisted of 75 persons who had PD and 75 normal people. The blood levels of lipid fractions were measured by concentrations of total cholesterol (TC), serum triglycerides (TG), low-density lipoprotein (LDL-C), high-density lipoprotein (HDL-C), and total cholesterol. The results were analyzed with SPSS software using Kolmogorov-Smirnov, chi-square, and student's t-test. RESULTS: Serum level of TG was remarkably lower in patients with PD (111.92±8.75 mg/dL) compared with healthy subjects (123.64±9.97 mg/dL, P=0.008). Furthermore, we saw an important difference in the level of LDL-C (P=0.001) and TC (P=0.004) between the two groups. However, there was not any observed meaningful difference in the serum concentrations of HDL-C between the studied groups (P=0.135). CONCLUSION: Our results showed that the serum concentration of TG, LDL-C, and TC are noticeably lower in the PD suffering patients. Further investigations are needed to provide comprehensive information on the participants' cognitive layout and subsequent actions.
format Online
Article
Text
id pubmed-8111816
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Babol University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-81118162021-05-18 Serum lipid profile of Parkinson's disease patients: A study from the Northwest of Iran Saedi, Samira Hemmati-Dinarvand, Mohsen Barmaki, Haleh Mokhtari, Zohreh Musavi, Hadis Valilo, Mohamad Mota, Ali Mahjoub, Soleiman Caspian J Intern Med Original Article BACKGROUND: Parkinson's disease (PD) is defined as a long-lasting, neurological illness. Low levels of serum lipid fractions are related with a high risk of PD. Current investigation was designed to evaluate the concentration blood lipid fractions in patients suffering from PD and compared with healthy subjects. METHODS: This case-control study was conducted from February 2016 to September 2018 in Tabriz University of Medical Sciences, Tabriz, Iran. The present investigation consisted of 75 persons who had PD and 75 normal people. The blood levels of lipid fractions were measured by concentrations of total cholesterol (TC), serum triglycerides (TG), low-density lipoprotein (LDL-C), high-density lipoprotein (HDL-C), and total cholesterol. The results were analyzed with SPSS software using Kolmogorov-Smirnov, chi-square, and student's t-test. RESULTS: Serum level of TG was remarkably lower in patients with PD (111.92±8.75 mg/dL) compared with healthy subjects (123.64±9.97 mg/dL, P=0.008). Furthermore, we saw an important difference in the level of LDL-C (P=0.001) and TC (P=0.004) between the two groups. However, there was not any observed meaningful difference in the serum concentrations of HDL-C between the studied groups (P=0.135). CONCLUSION: Our results showed that the serum concentration of TG, LDL-C, and TC are noticeably lower in the PD suffering patients. Further investigations are needed to provide comprehensive information on the participants' cognitive layout and subsequent actions. Babol University of Medical Sciences 2021-03 /pmc/articles/PMC8111816/ /pubmed/34012532 http://dx.doi.org/10.22088/cjim.12.2.155 Text en Copyright © 2020, Babol University of Medical Sciences https://creativecommons.org/licenses/by/3.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/ (https://creativecommons.org/licenses/by/3.0/) ) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Saedi, Samira
Hemmati-Dinarvand, Mohsen
Barmaki, Haleh
Mokhtari, Zohreh
Musavi, Hadis
Valilo, Mohamad
Mota, Ali
Mahjoub, Soleiman
Serum lipid profile of Parkinson's disease patients: A study from the Northwest of Iran
title Serum lipid profile of Parkinson's disease patients: A study from the Northwest of Iran
title_full Serum lipid profile of Parkinson's disease patients: A study from the Northwest of Iran
title_fullStr Serum lipid profile of Parkinson's disease patients: A study from the Northwest of Iran
title_full_unstemmed Serum lipid profile of Parkinson's disease patients: A study from the Northwest of Iran
title_short Serum lipid profile of Parkinson's disease patients: A study from the Northwest of Iran
title_sort serum lipid profile of parkinson's disease patients: a study from the northwest of iran
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111816/
https://www.ncbi.nlm.nih.gov/pubmed/34012532
http://dx.doi.org/10.22088/cjim.12.2.155
work_keys_str_mv AT saedisamira serumlipidprofileofparkinsonsdiseasepatientsastudyfromthenorthwestofiran
AT hemmatidinarvandmohsen serumlipidprofileofparkinsonsdiseasepatientsastudyfromthenorthwestofiran
AT barmakihaleh serumlipidprofileofparkinsonsdiseasepatientsastudyfromthenorthwestofiran
AT mokhtarizohreh serumlipidprofileofparkinsonsdiseasepatientsastudyfromthenorthwestofiran
AT musavihadis serumlipidprofileofparkinsonsdiseasepatientsastudyfromthenorthwestofiran
AT valilomohamad serumlipidprofileofparkinsonsdiseasepatientsastudyfromthenorthwestofiran
AT motaali serumlipidprofileofparkinsonsdiseasepatientsastudyfromthenorthwestofiran
AT mahjoubsoleiman serumlipidprofileofparkinsonsdiseasepatientsastudyfromthenorthwestofiran